Purified anti-mouse CD4 Antibody

Pricing & Availability
Clone
GK1.5 (See other available formats)
Regulatory Status
RUO
Other Names
L3T4, T4
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
GK1dot5_Pure_021706
BALB/c mouse splenocytes were stained with purified CD4 (clone GK1.5) (filled histogram) or rat IgG2b, κ isotype control (open histogram), followed by anti-rat IgG FITC.
  • GK1dot5_Pure_021706
    BALB/c mouse splenocytes were stained with purified CD4 (clone GK1.5) (filled histogram) or rat IgG2b, κ isotype control (open histogram), followed by anti-rat IgG FITC.
Compare all formats
Cat # Size Price Quantity Check Availability Save
100401 50 µg 20€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100402 500 µg 62€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD4 is a 55 kD protein also known as L3T4 or T4. It is a member of the Ig superfamily, primarily expressed on most thymocytes, a subset of T cells, and weakly on macrophages and dendritic cells. It acts as a coreceptor with the TCR during T cell activation and thymic differentiation by binding MHC class II and associating with the protein tyrosin kinase, lck.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse CTL clone V4
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
IHC-F, IP - Reported in the literature, not verified in house

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Additional reported applications (for the relevant formats) include: blocking of CD4+ T cell activation1,4,11, thymocyte costimulation3, in vitro and in vivo depletion2,5-8, blocking of egg-sperm cell adhesion1,4, immunohistochemical staining of acetone-fixed frozen sections9,10, immunoprecipitation1,2, and spatial biology (IBEX)12,13. The GK1.5 antibody is able to block CD4 mediated cell adhesion and T cell activation. Binding of GK1.5 antibody to CD4 T cells can be blocked by RM4-5 antibody, but not RM4-4 antibody. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 100442) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin < 0.01 EU/µg).

Application References
  1. Dialynas DP, et al. 1983. J. Immunol. 131:2445. (Block, IP)
  2. Dialynas DP, et al. 1983. Immunol. Rev. 74:29. (IP, Deplete)
  3. Wu L, et al. 1991. J. Exp. Med. 174:1617. (Costim)
  4. Godfrey DI, et al. 1994. J. Immunol. 152:4783. (Block)
  5. Gavett SH, et al. 1994. Am. J. Respir. Cell. Mol. Biol. 10:587. (Deplete)
  6. Schuyler M, et al. 1994. Am. J. Respir. Crit. Care Med. 149:1286. (Deplete)
  7. Ghobrial RR, et al. 1989. Clin. Immunol. Immunopathol. 52:486. (Deplete)
  8. Israelski DM, et al. 1989. J. Immunol. 142:954. (Deplete)
  9. Zheng B, et al. 1996. J. Exp. Med. 184:1083. (IHC)
  10. Frei K, et al. 1997. J. Exp. Med. 185:2177. (IHC)
  11. Felix NJ, et al. 2007. Nat. Immunol. 8:388. (Block)
  12. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  13. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Zhang S, et al. 2017. Nature.. 10.1038/nature24283. PubMed
  2. Chami B, et al. 2017. Sci Rep. 7:10181. PubMed
  3. Tsukumo S, et al. 2006. J Immunol. 177:8365. PubMed
  4. Kobayashi A, et al. 2021. Front Immunol. 12:650856. PubMed
  5. Liao X, et al. 2022. Front Immunol. 12:768813. PubMed
  6. Paterson MJ, et al. 2020. PLoS Pathog. 16:e1008733. PubMed
  7. Hummel JF, et al. 2020. Mucosal Immunol. 0.720138889. PubMed
  8. Smith CJ, et al. 2018. J Immunol. 200:1580. PubMed
  9. Mazor R, et al. 2018. Proc Natl Acad Sci U S A. 115:E733. PubMed
  10. Krovi SH, et al. 2019. Proc Natl Acad Sci U S A. 116:22252. PubMed
  11. Thelin MA, et al. 2017. Diabetes. 66:2220. PubMed
  12. Thi VAD, et al. 2019. Mol Cells. 42:869. PubMed
  13. Burrello C, et al. 2018. Front Med (Lausanne). 5:21. PubMed
  14. Shirakawa K, et al. 2017. PLoS One. 12:e0186303. PubMed
  15. Landuyt AE, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  16. Fernandes V, et al. 2020. PLoS Pathog. 16:e1008464. PubMed
  17. Bajaña S, et al. 2021. Front Immunol. 11:577718. PubMed
  18. Murata A, et al. 2020. Front Immunol. 11:775. PubMed
  19. Wan Mohd Zawawi WFA, et al. 2021. Sci Rep. 11:10278. PubMed
  20. Rieck M, et al. 2017. Eur J Immunol. 47:677. PubMed
  21. Duvvuri M, et al. 2019. Biomater Sci. 7:1863. PubMed
  22. Yang J, et al. 2020. Front Immunol. 10:3048. PubMed
  23. Prado C, et al. 2021. J Neuroinflammation. 18:292. PubMed
  24. Carpenter SM, et al. 2017. PLoS Pathog. 13:e1006704. PubMed
  25. Gao J, et al. 2017. Oncol Lett. 14:2954. PubMed
  26. Hashimoto K, et al. 2021. J Dermatol Sci. 102:177. PubMed
  27. Haque M, et al. 2021. Viruses. 13:. PubMed
  28. Mayer JU, et al. 2020. Front Immunol. 11:592325. PubMed
  29. Tian K, et al. 2021. J Immunol Res. 2021:6297332. PubMed
  30. Hirano J, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  31. Draganov D, et al. 2021. NPJ Breast Cancer. 7:22. PubMed
  32. Rossi DC, et al. 2021. J Clin Invest. 131:. PubMed
  33. Wabitsch S, et al. 2021. STAR Protoc. 2:100517. PubMed
  34. Schafflick D, et al. 2020. Nat Commun. 247:11. PubMed
  35. Xie MM, et al. 2017. Eur J Immunol. 47:1136. PubMed
  36. Zhou AC, et al. 2017. Front Immunol. 1.136111111. PubMed
  37. Niss Arfelt K, et al. 2017. Blood. 129:866. PubMed
  38. Stefanescu C, et al. 2021. Front Oncol. 11:765151. PubMed
  39. Mostafavi H, et al. 2022. PLoS Pathog. 18:e1010185. PubMed
  40. Tan L, et al. 2017. Int J Nanomedicine. 12:3095. PubMed
  41. McLeod RL, et al. 2018. Oncotarget. 9:34459. PubMed
  42. Jackson JW, et al. 2021. Mol Ther Oncolytics. 22:444. PubMed
  43. Mayer KA, et al. 2021. FASEB J. 35:e21217. PubMed
  44. Lasrado N, et al. 2021. Microorganisms. 9:. PubMed
  45. Shimokawa C et al. 2017. Immunity. 46(5):863-874 . PubMed
  46. Sun H, et al. 2018. J Cell Biol. 217:1453. PubMed
  47. Chen S, et al. 2018. Immunohorizons. 0.345138889. PubMed
  48. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  49. Wang N, et al. 2021. Mol Ther Oncolytics. 20:71. PubMed
  50. Skeate JG, et al. 2018. PLoS One. 13:e0191311. PubMed
  51. Seelige R, et al. 2018. Sci Rep. 8:13670. PubMed
  52. Yang SH, et al. 2017. Front Immunol. 8:1192. PubMed
  53. Zhao L, et al. 2018. Nat Med. 24:1536. PubMed
  54. Stacey MA, et al. 2017. J Clin Invest. 127:1463. PubMed
  55. Sharma M, et al. 2020. Nat Commun. 11:661. PubMed
  56. Ma W, et al. 2017. Sci Rep. . 10.1038/s41598-017-15661-6. PubMed
  57. Overacre-Delgoffe AE, et al. 2017. Cell. 169:1130. PubMed
  58. Elsayed H, et al. 2018. J Virol. 92:e00428. PubMed
  59. Gartlan KH, et al. 2019. Blood Adv. 2.110416667. PubMed
  60. Hu M, et al. 2008. J Immunol. 180:6593. PubMed
  61. Xie D, et al. 2020. Eur J Immunol. 50:1729. PubMed
  62. Shokirova H, et al. 2021. Sci Rep. 11:8647. PubMed
  63. Zareie P, et al. 2017. J Neuroinflammation. 0.630555556. PubMed
  64. Leal AS, et al. 2019. Sci Rep. 5.286111111. PubMed
  65. Hoves S, et al. 2018. J Exp Med. 215:859. PubMed
  66. Hsiao CC, et al. 2021. Cells. 10:. PubMed
  67. Horiuchi S, et al. 2021. Sci Immunol. :eabm3131. PubMed
  68. Kinosada H, et al. 2017. PLoS Pathog. 10.1371/journal.ppat.1006120. PubMed
  69. Pierini A, et al. 2017. JCI Insight. 2. PubMed
  70. Sprouse ML, et al. 2018. JCI Insight. 3:e97322. PubMed
  71. Lee JY, et al. 2018. Front Immunol. 0.678472222. PubMed
  72. Liu M, et al. 2018. Diabetologia. 61:2333. PubMed
  73. Sharabi A, et al. 2019. JCI Insight. 4:e126294. PubMed
  74. Majer O, et al. 2019. Nature. 575:366. PubMed
  75. Tao H, et al. 2021. Front Immunol. 12:623280. PubMed
  76. Zelazowska MA, et al. 2020. Life Sci Alliance. :3. PubMed
  77. Matsuo K, et al. 2018. J Invest Dermatol. 138:1764. PubMed
  78. Sendler M, et al. 2020. Gastroenterology. 158:253. PubMed
  79. Yates K, et al. 2018. Proc Natl Acad Sci U S A. 115:2162. PubMed
  80. Zhang H, et al. 2017. J Immunol. 198:2133. PubMed
  81. Simula L et al. 2018. Cell reports. 25(11):3059-3073 . PubMed
  82. Biton M et al. 2018. Cell. 175(5):1307-1320 . PubMed
  83. Zander R, et al. 2017. Cell Rep.. 10.1016/j.celrep.2017.10.077. PubMed
  84. De Ponte Conti B, et al. 2021. Elife. 10:. PubMed
  85. Chen HW, et al. 2021. Biomedicines. 9:. PubMed
  86. Ikezoe T, et al. 2021. Biomolecules. 11:. PubMed
  87. Shiozawa S, et al. 2022. iScience. 25:103537. PubMed
  88. Goh W, et al. 2020. Cell Rep. 33:108285. PubMed
  89. Chen X, et al. 2019. Methods Mol Biol. 2048:131. PubMed
  90. Rosenbaum M, et al. 2019. Nat Commun. 2.05. PubMed
  91. Meyers JL, et al. 2018. PLoS One. 13:e0207007. PubMed
  92. Floudas A, et al. 2017. J Immunol. 199:707. PubMed
  93. Zhang YN, et al. 2021. Sci Adv. 7:eabj3107. PubMed
  94. Pradhan P, et al. 2017. JCI Insight. 2. PubMed
  95. Song K, et al. 2017. Oncotarget. 8:38554. PubMed
  96. Akiel M, et al. 2017. Cancer Res. 77:4014. PubMed
  97. Duncan CG, et al. 2018. G3 (Bethesda). 0.892361111. PubMed
  98. Wilhelmson AS, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1519. PubMed
  99. Roussey JA, et al. 2017. J Immunol. 199:3535. PubMed
  100. Stefanski HE, et al. 2018. PLoS One. 13:e0198871. PubMed
  101. Scortegagna M, et al. 2020. Nat Commun. 11:99. PubMed
  102. Brownlie D, et al. 2021. J Immunother Cancer. 9:. PubMed
  103. Tsai MS, et al. 2021. Int J Mol Sci. 22:. PubMed
  104. Zhang Z, et al. 2020. Front Immunol. 1.844444444. PubMed
  105. Rosenberg J, et al. 2020. Cell Systems. 10(5):433-444. PubMed
  106. Scutts SR, et al. 2018. Cell Rep. 25:1953. PubMed
  107. Liu J, et al. 2022. Stem Cell Res Ther. 13:247. PubMed
  108. Lin Z, et al. 2021. Stem Cells. 39:240. PubMed
  109. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  110. Luu M, et al. 2019. Nat Commun. 10:760. PubMed
  111. Di Dalmazi G, et al. 2019. J Immunol. 202:1350. PubMed
  112. Dey P, et al. 2020. Cancer Discov. 10:608. PubMed
  113. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  114. Fujimura N, et al. 2016. J Vasc Surg. 64: 46-54. PubMed
  115. Englezou PC, et al. 2018. Mol Ther Nucleic Acids. 12:118. PubMed
  116. Cole C, et al. 2018. Nucleic Acids Res. 46:e62. PubMed
  117. Tang-Huau TL, et al. 2021. Viruses. 13: . PubMed
  118. Zhang J, et al. 2019. Onco Targets Ther. 12:4985. PubMed
  119. Zhang N, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  120. Whittle JR, et al. 2020. Clin Cancer Res. 26:4120. PubMed
  121. Liu H, et al. 2022. Animal Model Exp Med. 5:72. PubMed
  122. Krämer TJ, et al. 2019. J Neuroinflammation. 16:163. PubMed
  123. Shao Y, et al. 2017. Onco Targets Ther. 10:2675. PubMed
  124. He X, et al. 2017. Cancer Biol Ther. 0.815277778. PubMed
  125. Kästele V, et al. 2021. Mucosal Immunol. 14:717. PubMed
  126. Prabakaran T, et al. 2021. EBioMedicine. 66:103314. PubMed
  127. Sutiwisesak R, et al. 2020. PLoS Pathog. 16:e1009000. PubMed
RRID
AB_312686 (BioLegend Cat. No. 100401)
AB_312687 (BioLegend Cat. No. 100402)

Antigen Details

Structure
Ig superfamily, 55 kD
Distribution

Majority of thymocytes, T cell subset

Function
TCR co-receptor, T cell activation
Ligand/Receptor
MHC class II molecule
Cell Type
Dendritic cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Bierer BE, et al. 1989. Annu. Rev. Immunol. 7:579.
3. Janeway CA. 1992. Annu. Rev. Immunol. 10:645.

Gene ID
12504 View all products for this Gene ID
UniProt
View information about CD4 on UniProt.org

Related FAQs

I am unable to see expression of T cell markers such as CD3 and CD4 post activation.
TCR-CD3 complexes on the T-lymphocyte surface are rapidly downregulated upon activation with peptide-MHC complex, superantigen or cross-linking with anti-TCR or anti-CD3 antibodies. PMA/Ionomycin treatment has been shown to downregulate surface CD4 expression. Receptor downregulation is a common biological phenomenon and so make sure that your stimulation treatment is not causing it in your sample type.

Other Formats

View All CD4 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD4 GK1.5 FC
Biotin anti-mouse CD4 GK1.5 FC, IHC-F, ICC
FITC anti-mouse CD4 GK1.5 FC, IHC-F, ICC
PE anti-mouse CD4 GK1.5 FC
PE/Cyanine5 anti-mouse CD4 GK1.5 FC
Purified anti-mouse CD4 GK1.5 FC, IHC-F, ICC, IP, Costim, Block, Depletion
PE/Cyanine7 anti-mouse CD4 GK1.5 FC
APC/Cyanine7 anti-mouse CD4 GK1.5 FC
Alexa Fluor® 647 anti-mouse CD4 GK1.5 FC, IHC-F, ICC
Alexa Fluor® 488 anti-mouse CD4 GK1.5 FC, IHC-F, ICC
Pacific Blue™ anti-mouse CD4 GK1.5 FC
Alexa Fluor® 700 anti-mouse CD4 GK1.5 FC
PerCP anti-mouse CD4 GK1.5 FC
PerCP/Cyanine5.5 anti-mouse CD4 GK1.5 FC
Brilliant Violet 421™ anti-mouse CD4 GK1.5 FC, ICC, IHC-F
Ultra-LEAF™ Purified anti-mouse CD4 GK1.5 FC, Block, Costim, Depletion, IHC, IP
Alexa Fluor® 594 anti-mouse CD4 GK1.5 IHC-F, FC, ICC, SB
Brilliant Violet 711™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 510™ anti-mouse CD4 GK1.5 FC, IHC-F, ICC
Brilliant Violet 605™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 785™ anti-mouse CD4 GK1.5 FC
PE/Dazzle™ 594 anti-mouse CD4 GK1.5 FC
APC/Fire™ 750 anti-mouse CD4 GK1.5 FC
GoInVivo™ Purified anti-mouse CD4 GK1.5 FC
Brilliant Violet 750™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 650™ anti-mouse CD4 GK1.5 FC
Spark Blue™ 550 anti-mouse CD4 GK1.5 FC
Spark NIR™ 685 anti-mouse CD4 GK1.5 FC
KIRAVIA Blue 520™ anti-mouse CD4 GK1.5 FC
PE/Fire™ 640 anti-mouse CD4 GK1.5 FC
APC/Fire™ 810 anti-mouse CD4 GK1.5 FC
PE/Fire™ 700 anti-mouse CD4 GK1.5 FC
Spark Violet™ 538 anti-mouse CD4 GK1.5 FC
Spark YG™ 593 anti-mouse CD4 GK1.5 FC
Spark Blue™ 574 anti-mouse CD4 Antibody GK1.5 FC
Spark UV™ 387 anti-mouse CD4 GK1.5 FC
Go To Top Version: 1    Revision Date: 11/30/2012

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-mouse CD4

  • Biotin anti-mouse CD4

  • FITC anti-mouse CD4

  • PE anti-mouse CD4

  • PE/Cyanine5 anti-mouse CD4

  • Purified anti-mouse CD4

  • PE/Cyanine7 anti-mouse CD4

  • APC/Cyanine7 anti-mouse CD4

  • Alexa Fluor® 647 anti-mouse CD4

  • Alexa Fluor® 488 anti-mouse CD4

  • Pacific Blue™ anti-mouse CD4

  • Alexa Fluor® 700 anti-mouse CD4

  • PerCP anti-mouse CD4

  • PerCP/Cyanine5.5 anti-mouse CD4

  • Brilliant Violet 421™ anti-mouse CD4

  • Ultra-LEAF™ Purified anti-mouse CD4

  • Alexa Fluor® 594 anti-mouse CD4

  • Brilliant Violet 711™ anti-mouse CD4

  • Brilliant Violet 510™ anti-mouse CD4

  • Brilliant Violet 605™ anti-mouse CD4

  • Brilliant Violet 785™ anti-mouse CD4

  • PE/Dazzle™ 594 anti-mouse CD4

  • APC/Fire™ 750 anti-mouse CD4

  • GoInVivo™ Purified anti-mouse CD4

  • Brilliant Violet 750™ anti-mouse CD4

  • Brilliant Violet 650™ anti-mouse CD4

  • Spark Blue™ 550 anti-mouse CD4

  • Spark NIR™ 685 anti-mouse CD4

  • KIRAVIA Blue 520™ anti-mouse CD4

  • PE/Fire™ 640 anti-mouse CD4

  • APC/Fire™ 810 anti-mouse CD4

  • PE/Fire™ 700 anti-mouse CD4

  • Spark Violet™ 538 anti-mouse CD4

  • Spark YG™ 593 anti-mouse CD4

  • Spark Blue™ 574 anti-mouse CD4 Antibody

  • Spark UV™ 387 anti-mouse CD4

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account